Cargando…

Are the High Serum Interleukin-6 and Vascular Endothelial Growth Factor Levels Useful Prognostic Markers in Aggressive Non-Hodgkin Lymphoma Patients?

OBJECTIVE: Pro-inflammatory and pro-angiogenic cytokines play an important role in the pathogenesis of lymphoma, and recent studies have shown that cytokines can be used as prognostic markers. Non-Hodgkin lymphoma (NHL) patients with high levels of serum interleukin-6 (s-IL6) and serum vascular endo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Üsküdar Teke, Hava, Gündüz, Eren, Akay, Olga Meltem, Bal, Cengiz, Gülbaş, Zafer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439903/ https://www.ncbi.nlm.nih.gov/pubmed/25805671 http://dx.doi.org/10.4274/tjh.2013.0325

Ejemplares similares

Blastic Plasmacytoid Dendritic Cell Leukemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation to a Remission of 48-Month Duration
por: Goren Sahin, Deniz, et al.
Publicado: (2013)

Unusual Manifestations of Vincristine Neuropathy: Report of Two Cases of Hodgkin Lymphoma
por: Akay, Olga Meltem, et al.
Publicado: (2014)

Management of Relapsed Hodgkin Lymphoma During the Second Trimester of Pregnancy: Case Report
por: Yaman, Fatih, et al.
Publicado: (2023)

Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report
por: Üsküdar Teke, Hava, et al.
Publicado: (2014)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

The Frequency and Clinical Relevance of Multidrug Resistance Protein Expression in Patients with Lymphoma
por: Gündüz, Eren, et al.
Publicado: (2012)

Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
por: Durak Aras, Beyhan, et al.
Publicado: (2021)

Menorrhagia due to uterine amyloidosis in familial Mediterranean fever: case-based review
por: Cansu, Döndü Üsküdar, et al.
Publicado: (2020)

Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience
por: Üsküdar Cansu, Döndü, et al.
Publicado: (2021)

Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
por: Akay, Olga Meltem, et al.
Publicado: (2016)

Hepatitis B Virus Reactivation under Treatment with Nilotinib
por: Temel, Tuncer, et al.
Publicado: (2015)

Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
por: Gündüz, Eren, et al.
Publicado: (2012)

Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive Multiple Myeloma Diseases: A Case Report
por: Teke, Hava Üsküdar, et al.
Publicado: (2014)

Blue Lunula Related with Hydroxyurea
por: Üsküdar Teke, Hava, et al.
Publicado: (2013)

Splenic Infarct in a Patient with Autoimmune Hemolytic Anemia
por: Üsküdar Teke, Hava, et al.
Publicado: (2012)

The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)
por: Işık, Sevgi, et al.
Publicado: (2022)

Primary Pleural Diffuse Large B-cell non-Hodgkin’s Lymphoma Diagnosed via [18F]-2-Fluoro-Deoxy-DGlucose Positron Emission Tomography /Computed Tomography
por: Sivrikoz, İlknur Ak, et al.
Publicado: (2012)

Clinical Significance of Reticulocyte Hemoglobin Content in the Diagnosis of Iron Deficiency Anemia
por: Karagülle, Mustafa, et al.
Publicado: (2013)

Isolated Granulocytic Sarcoma of the Breast after Allogeneic Stem Cell Transplantation: A Rare Involvement Also Detected by 18FDG-PET/CT
por: Gündüz, Eren, et al.
Publicado: (2014)

HIV-ASSOCIATED NON HODGKIN LYMPHOMA: A CASE SERIES STUDY FROM TURKEY
por: Somay, Kayra, et al.
Publicado: (2020)

The Effect of Hyperparathyroid State on Platelet Functions and Bone Loss
por: Yorulmaz, Göknur, et al.
Publicado: (2016)

Stem cell therapy for congestive heart failure
por: Gunduz, E, et al.
Publicado: (2011)

A New Case of dic(1;15)(p11;p11) in AML M1: Apropos of a Case and a Review of the Literature
por: Şahin, Deniz Gören, et al.
Publicado: (2013)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
por: Durak, Beyhan Aras, et al.
Publicado: (2012)

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi
por: Gopal, Satish, et al.
Publicado: (2016)

Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Alessa, Mohammed A., et al.
Publicado: (2015)

Extranodal large B-cell type aggressive non-Hodgkin's lymphoma
por: Batra, Ranmeet, et al.
Publicado: (2014)

Aggressive squamous cell carcinoma as a harbinger of non-Hodgkin lymphoma
por: Callaghan, Daniel J., et al.
Publicado: (2018)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
por: Kang, Ka-Won, et al.
Publicado: (2018)

Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma
por: Oelmann, Elisabeth, et al.
Publicado: (2015)

Bulky Pelvic Hodgkin Lymphoma in a Prepubertal Girl
por: Totadri, Sidharth, et al.
Publicado: (2017)

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?
por: Hackshaw, A, et al.
Publicado: (2004)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy
por: Schmitz, Christine, et al.
Publicado: (2020)

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin’s Lymphomas
por: Ramadan, Safaa, et al.
Publicado: (2021)

The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Dudová, Lucie, et al.
Publicado: (2023)

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
por: Lynch, Ryan C., et al.
Publicado: (2022)

Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma
por: Passalidou, E, et al.
Publicado: (2003)

Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview
por: Rodrigues, Wellington Francisco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qo5f0sstpf1jl1rgst3iorjhcc